Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss
Russell T Turner1, Michael Dube2, Adam J Branscum2
1Skeletal Biology LaboratorySchool of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon 97331, USACenter for Healthy Aging ResearchOregon State University, Corvallis, Oregon, USADepartment of NeuroscienceMcKnight Brain Institute, University of Florida, Gainesville, Florida, USABiostatisticsSchool of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon, USADepartment of Physiological SciencesUniversity of Florida, Gainesville, Florida, USADepartment of Large Animal Clinical SciencesUniversity of Florida, Gainesville, Florida, USAMaine Medical Center Research InstituteScarborough, Maine, USA Skeletal Biology LaboratorySchool of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon 97331, USACenter for Healthy Aging ResearchOregon State University, Corvallis, Oregon, USADepartment of NeuroscienceMcKnight Brain Institute, University of Florida, Gainesville, Florida, USABiostatisticsSchool of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon, USADepartment of Physiological SciencesUniversity of Florida, Gainesville, Florida, USADepartment of Large Animal Clinical SciencesUniversity of Florida, Gainesville, Florida, USAMaine Medical Center Research InstituteScarborough, Maine, USA.
Hypothalamic leptin gene therapy effectively reduced weight in rats without negatively impacting bone health. This gene therapy offers a promising avenue for weight management with minimal adverse skeletal effects.
Area of Science:
- Metabolic research
- Bone biology
- Gene therapy
Background:
- Excessive weight gain poses significant health risks.
- Current weight management strategies (diet, exercise, drugs) have limited long-term success and potential side effects.
- Age-related bone loss is a concern, and its interaction with weight management needs further study.
Purpose of the Study:
- To evaluate the efficacy of hypothalamic leptin gene therapy for weight reduction in adult female rats.
- To determine the impact of leptin-induced weight loss on bone mass, density, and microarchitecture.
- To assess changes in serum biomarkers of bone turnover following leptin gene therapy.
Main Methods:
- Adult female rats received hypothalamic injections of either recombinant adeno-associated virus encoding rat leptin (rAAV-Leptin) or a control vector (rAAV-GFP).
- Body weight, adipose tissue, and serum biomarkers were measured over 18 weeks.
- Bone mass, density, and microarchitecture of cancellous bone were analyzed post-mortem.
Main Results:
- Rats treated with rAAV-Leptin exhibited significant weight loss compared to rAAV-GFP controls.
- Leptin-treated rats showed reduced abdominal white adipose tissue, serum leptin, and serum IGF1.
- No significant differences in cancellous bone parameters or bone turnover markers were observed between the rAAV-Leptin and rAAV-GFP groups.
Conclusions:
- Hypothalamic leptin gene therapy is effective in inducing weight loss in rats.
- This weight loss was achieved with minimal adverse effects on bone mass, density, microarchitecture, or bone turnover markers.
- Leptin gene therapy presents a potential therapeutic strategy for weight management without compromising skeletal integrity.
Related Concept Videos
01:30Regulation of Food Intake
01:16Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:24Obesity
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...